[HTML][HTML] Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events

P Jobanputra, R Amarasena, F Maggs… - BMC musculoskeletal …, 2008 - Springer
Background Spontaneous reporting systems for adverse drug reactions (ADRs) are handicapped
by under-reporting and limited detail on individual cases. We report an investigation …

Sjögren's syndrome

R Amarasena, S Bowman - Clinical medicine, 2007 - ncbi.nlm.nih.gov
Labial gland biopsy may be needed to confirm the diagnosis in PSS patients who do not have
anti-Ro or anti-La antibodies. This should be performed by an expert. Chronic sialadenitis …

Tocilizumab-induced pulmonary fibrosis in a patient with rheumatoid arthritis

S Silva, R Amarasena, J Moorcroft… - Clinical …, 2020 - ncbi.nlm.nih.gov
Materials and methods This case report is about a patient with RA who developed severe
acute pneumonitis after treatment with tocilizumab. An 82-year-old woman who had …

Acute visual loss without concurrent headaches due to ultrasound-negative, biopsy-proven giant cell arteritis

…, T Rajakulenthiran, S Silva, R Amarasena - Clinical Medicine, 2020 - rcpjournals.org
Materials and methods An 82-year-old Caucasian woman presented with blurring and greying
of her peripheral visual fields in the right eye. She later returned home due to extended …

Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)

…, A Moorthy, R Amarasena… - … Advances in Practice, 2023 - academic.oup.com
DEAR EDITOR, In recent years, more drug options have been approved for the treatment of
AS, one of which is the IL-17A inhibitor secukinumab [1]. Secukinumab was approved for …

P198 Efficacy and safety of secukinumab in ankylosing spondylitis: real-world data from Midlands Ankylosing Spondylitis Collaboration (MASC)

…, R Laxminarayan, A Moorthy, R Amarasena… - …, 2021 - academic.oup.com
Background/Aims Secukinumab is an interleukin-17 inhibitor has been found to be effective
in the treatment of ankylosing spondylitis (AS) in studies, including phase 3 clinical trials, …

Rare case of overlap of myositis and myasthenia gravis

S Zeb, A Sagdeo, R Amarasena - Clinical Medicine, 2022 - rcpjournals.org
Background Myositis and myasthenia gravis (MG) are both autoimmune disorders presenting
with muscle weakness. So far, only fewer than 50 cases of co-existence of myositis and …

The importance of skin biopsies: Sweet syndrome as a differential for 'acute painful red rash'in a patient with normal neutrophils and polymyalgia rheumatica on …

TG Rajakulenthiran, R Amarasena, R Singh… - Clinical …, 2020 - rcpjournals.org
Materials and methods A 76-year-old woman with polymyalgia rheumatica, large vessel
vasculitis, myelodysplasia and polycythaemia rubra vera presented with a painful red rash. Her …

[HTML][HTML] Experience with Adalimumab Biosimilar in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis at our District General Hospital in Shropshire …

A Sagdeo, A Sagdeo, R Amarasena - Vidarbha Journal of Internal Medicine, 2022 - vjim.org
Objectives: The main objective of this article was to share our experience with Idacio (adalimumab
biosimilar) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and …

Sarcoid arthropathy

JV McGowan, R Amarasena, A Ismail - 123doc.com
A 42 year old Afro-Caribbean male attended the rheumatology clinic with a 4 year history of
swelling of the joints in his hands. He denied early morning stiffness, joint involvement …